INVESTIGATION OF CIPROFLOXACIN PENETRATION INTO PSEUDOMONAS-AERUGINOSA BIOFILMS

被引:240
|
作者
SUCI, PA [1 ]
MITTELMAN, MW [1 ]
YU, FP [1 ]
GEESEY, GG [1 ]
机构
[1] TORONTO HOSP, CTR INFECT & BIOMAT RES, TORONTO M5G 2C4, ON, CANADA
关键词
D O I
10.1128/AAC.38.9.2125
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacterial infections associated with indwelling medical devices often demonstrate an intrinsic resistance to antimicrobial therapies. In order to explore the possibility of transport limitation to biofilm bacteria as a contributing factor, the penetration of a fluoroquinolone antibiotic, ciprofloxacin, through Pseudomonas aeruginosa biofilms was investigated. Attenuated total reflection Fourier transform infrared (ATR/FT-IR) spectrometry was employed to monitor bacterial colonization of a germanium substratum, transport of ciprofloxacin to the biofilm-substratum interface, and interaction of biofilm components with the antibiotic in a flowing system. Transport of the antibiotic to the biofilm-substratum interface during the 21-min exposure to 100 mu g/ml was found to be significantly impeded by the biofilm. Significant changes in IR bands of the biofilm in regions of the spectrum associated with RNA and DNA vibrational modes appeared following exposure to the antibiotic, indicating chemical modification of biofilm components. These results suggest that transport limitations may be an important factor in the antimicrobial resistance of biofilm bacteria and that ATR/FT-IR spectrometry may be used to follow the time course of antimicrobial action in biofilms in situ.
引用
收藏
页码:2125 / 2133
页数:9
相关论文
共 50 条
  • [1] CIPROFLOXACIN FOR PSEUDOMONAS-AERUGINOSA MENINGITIS
    MILLAR, MR
    BRANSBYZACHARY, MA
    TOMPKINS, DS
    HAWKEY, PM
    GIBSON, RM
    [J]. LANCET, 1986, 1 (8493): : 1325 - 1325
  • [2] MECHANISM OF CIPROFLOXACIN RESISTANCE IN PSEUDOMONAS-AERUGINOSA
    KAATZ, GW
    SEO, SM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (03): : 537 - 541
  • [4] MODULATION OF BIOFILMS OF PSEUDOMONAS-AERUGINOSA BY QUINOLONES
    YASSIEN, M
    KHARDORI, N
    AHMEDY, A
    TOAMA, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) : 2262 - 2268
  • [5] COMPLEMENT ACTIVATION BY PSEUDOMONAS-AERUGINOSA BIOFILMS
    JENSEN, ET
    KHARAZMI, A
    GARRED, P
    KRONBORG, G
    FOMSGAARD, A
    MOLLNES, TE
    HOIBY, N
    [J]. MICROBIAL PATHOGENESIS, 1993, 15 (05) : 377 - 388
  • [6] USE OF CIPROFLOXACIN IN THE TREATMENT OF PSEUDOMONAS-AERUGINOSA INFECTIONS
    FOLLATH, F
    BINDSCHEDLER, M
    WENK, M
    FREI, R
    STALDER, H
    REBER, H
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) : 236 - 240
  • [7] FACTORS INFLUENCING THE ACCUMULATION OF CIPROFLOXACIN IN PSEUDOMONAS-AERUGINOSA
    CELESK, RA
    ROBILLARD, NJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (11) : 1921 - 1926
  • [8] EVALUATION OF CIPROFLOXACIN IN THE TREATMENT OF PSEUDOMONAS-AERUGINOSA INFECTIONS
    GIAMARELLOU, H
    GALANAKIS, N
    DENDRINOS, C
    STEFANOU, J
    DAPHNIS, E
    DAIKOS, GK
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) : 232 - 235
  • [9] EFFECTS OF CIPROFLOXACIN AND PROTAMINE SULFATE COMBINATIONS AGAINST CATHETER-ASSOCIATED PSEUDOMONAS-AERUGINOSA BIOFILMS
    SOBOH, F
    KHOURY, AE
    ZAMBONI, AC
    DAVIDSON, D
    MITTELMAN, MW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) : 1281 - 1286
  • [10] CIPROFLOXACIN TREATMENT OF PERIAPICAL PSEUDOMONAS-AERUGINOSA INFECTION
    BARNETT, F
    AXELROD, P
    TRONSTAD, L
    SLOTS, J
    GRAZIANI, A
    TALBOT, G
    [J]. ENDODONTICS & DENTAL TRAUMATOLOGY, 1988, 4 (03): : 132 - 137